97 related articles for article (PubMed ID: 24565899)
1. Chronotherapeutic delivery of hydroxypropylmethylcellulose based mini-tablets: an in vitro-in vivo correlation.
Biswas N; Sahoo RK; Guha A; Kuotsu K
Int J Biol Macromol; 2014 May; 66():179-85. PubMed ID: 24565899
[TBL] [Abstract][Full Text] [Related]
2. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
3. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
[TBL] [Abstract][Full Text] [Related]
4. Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation.
Mittapalli RK; Nuthalapati S; Delke DeBord AE; Xiong H
Pharm Res; 2017 Jun; 34(6):1187-1192. PubMed ID: 28243955
[TBL] [Abstract][Full Text] [Related]
5. Thermal sintering: a novel technique used in the design, optimization and biopharmaceutical evaluation of propranolol HCl gastric floating tablets.
Venkata Srikanth M; Songa AS; Nali SR; Battu JR; Kolapalli VR
Drug Dev Ind Pharm; 2014 Jan; 40(1):33-45. PubMed ID: 23317339
[TBL] [Abstract][Full Text] [Related]
6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
7. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.
Yaro P; He X; Liu W; Xun M; Ma Y; Li Z; Shi X
Drug Dev Ind Pharm; 2014 Dec; 40(12):1670-6. PubMed ID: 24102615
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of mini-tablets-filled-pulsincap delivery of lornoxicam in the chronotherapeutic treatment of rheumatoid arthritis.
Hadi MA; Rao NG; Rao AS
Pak J Pharm Sci; 2015 Jan; 28(1):185-93. PubMed ID: 25553695
[TBL] [Abstract][Full Text] [Related]
9. Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets.
Eddington ND; Ashraf M; Augsburger LL; Leslie JL; Fossler MJ; Lesko LJ; Shah VP; Rekhi GS
Pharm Dev Technol; 1998 Nov; 3(4):535-47. PubMed ID: 9834957
[TBL] [Abstract][Full Text] [Related]
10. Pulse release of doxazosin from hydroxyethylcellulose compression coated tablet: mechanistic and in vivo study.
Biswas N; Guha A; Sahoo RK; Kuotsu K
Int J Biol Macromol; 2015 Jan; 72():537-43. PubMed ID: 25179280
[TBL] [Abstract][Full Text] [Related]
11. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
12. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride.
Bendas ER
Arch Pharm Res; 2009 Sep; 32(9):1317-29. PubMed ID: 19784589
[TBL] [Abstract][Full Text] [Related]
13. Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation.
Eddington ND; Marroum P; Uppoor R; Hussain A; Augsburger L
Pharm Res; 1998 Mar; 15(3):466-73. PubMed ID: 9563079
[TBL] [Abstract][Full Text] [Related]
14. Novel extended in vitro-in vivo correlation model for the development of extended-release formulations for baclofen: From formulation composition to in vivo pharmacokinetics.
Kim TH; Bulitta JB; Kim DH; Shin S; Shin BS
Int J Pharm; 2019 Feb; 556():276-286. PubMed ID: 30543888
[TBL] [Abstract][Full Text] [Related]
15. Development of In Vitro-In Vivo Correlation for Amorphous Solid Dispersion Immediate-Release Suvorexant Tablets and Application to Clinically Relevant Dissolution Specifications and In-Process Controls.
Kesisoglou F; Hermans A; Neu C; Yee KL; Palcza J; Miller J
J Pharm Sci; 2015 Sep; 104(9):2913-22. PubMed ID: 25611455
[TBL] [Abstract][Full Text] [Related]
16. Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC).
Dutta S; Qiu Y; Samara E; Cao G; Granneman GR
J Pharm Sci; 2005 Sep; 94(9):1949-56. PubMed ID: 16052544
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
[TBL] [Abstract][Full Text] [Related]
18. The influence of hydroxypropyl methylcellulose (HPMC) molecular weight, concentration and effect of food on in vivo erosion behavior of HPMC matrix tablets.
Jain AK; Söderlind E; Viridén A; Schug B; Abrahamsson B; Knopke C; Tajarobi F; Blume H; Anschütz M; Welinder A; Richardson S; Nagel S; Abrahmsén-Alami S; Weitschies W
J Control Release; 2014 Aug; 187():50-8. PubMed ID: 24818771
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices.
Ghori MU; Ginting G; Smith AM; Conway BR
Int J Pharm; 2014 Apr; 465(1-2):405-12. PubMed ID: 24560637
[TBL] [Abstract][Full Text] [Related]
20. Controlled transdermal delivery of propranolol using HPMC matrices: design and in-vitro and in-vivo evaluation.
Verma PR; Iyer SS
J Pharm Pharmacol; 2000 Feb; 52(2):151-6. PubMed ID: 10714944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
